Amalaki rasayana and max HB in sickle cell anaemia: An open label non-comparative clinical trial
Bioinformation · 31.10.2026 · 22 (10) · 7409-7414
DOI: 10.6026/973206300227409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Amit Nampalliwar.
Abstract (Originalsprache)
Sickle cell anaemia is an inherited hemoglobin disorder characterized by sickling of red blood cells, leading to vaso-occlusion, chronic anaemia and recurrent systemic complications. Therefore, it is of interest to evaluate the clinical efficacy of Amalaki Rasayana and Capsule Max HB in the management of sickle cell anaemia. An open-label, non-comparative clinical trial was conducted on 25 patients at Government Ayurveda College and Hospital, Bilaspur, Chhattisgarh, with outcomes assessed over 60 days using the Dutch-AIMS2-HFF Symptoms Severity Scale, Wilcoxon Signed Rank Test and paired t-test. Treatment produced significant improvements in subjective symptoms, including anaemia (35.71%), pallor (43.40%), bodyache (37.50%), palpitation (43.86%), hand-foot syndrome (25.58%), loss of appetite (41.18%) and recurrent respiratory infection (37.78%), with an overall improvement of 37.86%, alongside increases in Hb, RBC, MCH, MCV and MCHC. Thus, combined Amalaki Rasayana and Capsule Max HB therapy showed clinically meaningful improvement in symptomatic and hematological parameters, supporting its potential as an adjunctive Ayurvedic intervention for sickle cell anaemia.
Zitieren
APA
Nampalliwar, A. (2026). Amalaki rasayana and max HB in sickle cell anaemia: An open label non-comparative clinical trial. Bioinformation, 22(10), 7409-7414. https://doi.org/10.6026/973206300227409
Vancouver
Nampalliwar A. Amalaki rasayana and max HB in sickle cell anaemia: An open label non-comparative clinical trial. Bioinformation. 2026;22(10):7409-7414. doi:10.6026/973206300227409
BibTeX
@article{Nampalliwar2026,
author = {Nampalliwar, Amit},
title = {Amalaki rasayana and max HB in sickle cell anaemia: An open label non-comparative clinical trial},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {7409--7414},
doi = {10.6026/973206300227409}
}
EUVIMED